anthropic4 min read
OpenAI acquires Orchestra Bio to bring AI agents into drug development
OpenAI Group PBC revealed today that it has acquired drug development software startup Orchestra Bio Inc. Orchestra builds artificial intelligence agents that help pharmaceutical teams keep development programs on track,.
By Duncan RileySiliconANGLE

Read the full story
Originally published by SiliconANGLE on Oct 20, 2026.
Comments
Sign in to join the discussion.